BioCentury
ARTICLE | Company News

CPEX deal

January 18, 2010 8:00 AM UTC

In an SEC filing, private equity firm Arcadia Capital proposed to acquire the 88% of CPEX it does not already own for $14.00 per share, or about $31.3 million. The price is a 24% premium to CPEX's clo...